leisure time -WSS

leisure time

author：fashion 2025-09-29 12:09:06 - browse：23951

Pfizer is this year’s anti-Eli Lilly. If David Ricks is the best biopharma CEO of 2023, then Pfizer CEO Albert Bourlais, unfortunately, the worst.

My annual Worst Biopharma CEO list is typically populated with blockheads and scoundrels. That’s not why Bourla is here. The reason is accountability. Strategic missteps, financial miscalculations, and scientific setbacks have plunged Pfizer into a deep crisis. Bourla is the man at the top, so the responsibility lies with him.

Pfizer shares have fallen 50% this year to their lowest level in more than a decade, erasing nearly $140 billion in market value. In 2022, the company delivered $100 billion in revenue, boosted by a widely used Covid vaccine and Covid treatment. This year, Covid product sales evaporated — and will fall further next year — leaving a vacuum Pfizer is struggling to fill with aging medicines nearing the end of their patent lives, and newer drugs and vaccines that have not performed as expected.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How to save PrEP access — and even expand it
Next article： Readout Newsletter: The latest on Novavax, Merck, Bluebird

hotspot

WSS

Fertility clinic egg and embryo storage is a disaster

Why H5N1 bird flu is keeping the CDC's top flu scientist awake

What a koala virus tells us about the human genome

Merck, Johnson & Johnson CEOs will testify on high drug prices

Supreme Court to hear if Covid misinformation is protected speech

Bernie Sanders is gearing up to subpoena pharma CEOs

hotspot

leisure time

leisure time

Medicare details structure of new drug price negotiation program

Raw milk easy to obtain despite bird flu warning, FDA interstate ban

Alkermes shareholders re

Readout Newsletter: Biogen, Ionis, Johnson & Johnson news

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Supreme Court to hear if Covid misinformation is protected speech

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Syphilis numbers in the United States reach record heights

Cancer drug shortages should be causing more outrage

FTC sues over Novant Health acquisition of two N.C. hospitals

explore

Medicare drug price negotiation legal challenge met with skepticism

Raw milk easy to obtain despite bird flu warning, FDA interstate ban

Lilly’s weekly insulin works as well as daily products, new studies show

Readout Newsletter: CG Oncology IPO, Eli Lilly, Tesla, Merck

Biogen walks away from Aduhelm, years after polarizing approval

Reconstructing family trees of blood cells may help predict disease

explore

hotspot

focus

explore